Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › MicroRNA-33 inhibitors and use thereof in the treatment of pulmonary fibrosis

MicroRNA-33 inhibitors and use thereof in the treatment of pulmonary fibrosis

US Patent 12060555 · Granted Aug 13, 2024

Estimated economic value: $201,433,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Template-directed nucleic acid targeting compounds2024
Discoidal nano universal platform for efficient delivery of PNAs2023
Compositions and methods of treating or preventing fibrotic lung diseases2023
Template-directed PNA synthesis process and PNA targeting compounds2022
Compositions for enhancing targeted gene editing and methods of use thereof2021
Biomarkers for assessing idiopathic pulmonary fibrosis2021
52-gene signature in peripheral blood identifies a genomic profile associated wi2021
Methods of treating or preventing fibrotic lung diseases2020
Template-directed γPNA synthesis process and γPNA targeting compounds2019
Anti-miR-27b and anti-miR-148a oligonucleotides as therapeutic tools for treatin2018
Biomarkers for assessing idiopathic pulmonary fibrosis2018
Methods of treating or preventing fibrotic lung diseases2018